# Biomat USA, Inc. – FDA Inspection, Mar 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5722e8d4-b7f2-495b-bd9c-bd1123aa0458
Source feed: FDA_Inspections

> FDA inspection 1167592 of Biomat USA, Inc., March 17, 2022. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167592
- Company Name: Biomat USA, Inc.
- Inspection Date: 2022-03-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1015150 - 2017-06-07
- FDA Inspection 903957 - 2014-11-14
- FDA Inspection 805513 - 2012-10-16
- FDA Inspection 722053 - 2011-04-27
- FDA Inspection 578255 - 2009-04-21

Company: https://www.keypedia.com/companies/biomat-usa-inc/ccc26b45-b9b6-4395-88ca-26df055c5b63

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d